Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes
Our results highlight the complex interplay between metabolic disturbances, immune responses, and TB pathology in the context of PDM, particularly highlighting the impact of changes in HbA1c levels. This emphasizes the need for specialized approaches to manage and treat TB-PDM comorbidity.
Authors
- Nathella Pavan Kumar (ORCID: https://orcid.org/0000-0003-2969-2621)
- Hardy Kornfeld (ORCID: https://orcid.org/0000-0002-8970-7306)
- Vijay Viswanathan (ORCID: https://orcid.org/0000-0001-9116-3937)
- Sujatha Nott
- Subash Babu (ORCID: https://orcid.org/0000-0001-9783-8042)
- Syed S Hissar (ORCID: https://orcid.org/0000-0003-0905-1552)
- Anuradha Rajamanickam (ORCID: https://orcid.org/0000-0002-8143-5502)
- Sanaadhan P. Kothandaraman
- Sivakumar Shanmugam
Institutions
- National Institutes of Health (US)
- University of Massachusetts Chan Medical School (US)
- Stanley Medical College (IN)
- Dignity Health (US)
- Indian Council of Medical Research (IN)
- India Diabetes Research Foundation (IN)
- International Centers for Excellence in Research (IN)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fimmu.2024.1447161
- Citations
- 6
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- CRDF Global
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research